Peptide
Endoluten
Also known as
Endoluten pineal bioregulator · pineal gland peptide complex
Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.
What it is
| Identity | An oral peptide complex from animal pineal tissue, also called A-8, discussed for sleep and calm. It is a mixture, distinct from synthetic Epithalon; capsule counts cannot be converted into injection amounts. |
|---|
Notes
Endoluten is an oral animal-pineal peptide complex discussed for sleep, calm and longevity. Reports include better sleep and reduced mental chatter, but also reduced sexual arousal and no lucid-dream benefit. These experiences do not establish longer life or reliable hormone changes.
A-8 is a tissue-derived mixture. The retail identity is a peptide complex from young-animal pineal tissue. Bioregulator is the term used for the idea of supporting the organ the extract came from; the name itself does not establish that effect. Qi Endoluten product panel and commercial description (Official context · Accessed 2026-09-30)
Capsules and Epithalon are different products. Forums often call Endoluten oral Epithalon. That shorthand blurs an extract and a synthetic peptide. Capsule counts cannot be converted into an equivalent injection amount, and results from one form cannot simply be assigned to the other. Conflicting Endoluten and Epithalon comparisons (Community discussion · Accessed 2026-09-30)
Source context — Qi Endoluten product panel and commercial description: Commercial reproduced label, not regulator guidance or independent testing. official_context is the available label-context role, not endorsement of the vendor as an official health authority. Absorption/gene-expression/benefit and safety assurances not adopted; customer reviews were not visible in the opened body.
Source context — Conflicting Endoluten and Epithalon comparisons: Small unverified individual comparisons; doses/products/conditions uncontrolled. Repeated mikey posts are one person's account. Study/superiority, military-origin and mechanism claims not adopted.
What people notice
| Sleep and calm | One oral-course author reports better sleep, less anxiety and mild euphoria. A Vladonix–Endoluten account describes deeper sleep without separating the two products. |
|---|---|
| Dreams and libido vary | The ten-day diarist recalled dreams early but achieved no lucid dreams and reported reduced arousal. Another author reported greater sexual interest and morning erections. |
Notes
Better sleep and a calmer mood. Alin Samson's oral-course updates describe improved sleep, less anxiety and mild euphoria. A separate Vladonix-Endoluten account describes deeper sleep, but both products were used together. Alin Samson's oral Endoluten course updates (Personal report · Accessed 2026-09-30) · Vladonix and Endoluten combined-use report (Personal report · Accessed 2026-09-30)
Dream recall is different from lucid dreaming. Remembering a dream does not mean recognizing that you are dreaming while it happens. The ten-day diarist recalled dreams early on but did not achieve the lucid dreams they wanted. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
Calm can come with an unwanted sexual change. The dream diarist's reduced arousal was marked by day five. Their later follow-up says it was not after the first capsule. Sleepiness and changes in sexual interest are relevant even if someone also feels calmer. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30) · Same diarist's later libido and dream recollections (Personal report · Accessed 2026-09-30)
Libido accounts point in opposite directions. Alin reported increased sexual interest and morning erections; the dream diarist reported reduced arousal. Different people and unverified products cannot establish why their experiences differed. Alin Samson's oral Endoluten course updates (Personal report · Accessed 2026-09-30) · Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
Dream benefits were inconsistent even in one account. The diarist's early updates mention improved recall; a later recollection says there were no dreams, lucid or otherwise. The disagreement belongs within that person's story, rather than becoming two separate users or a reliable dream effect. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30) · Same diarist's later libido and dream recollections (Personal report · Accessed 2026-09-30)
Source context — Alin Samson's oral Endoluten course updates: Anonymous unblinded account; no dose/strength given, expectations uncontrolled. Includes supplier endorsement, which is not reproduced. Mirror blog repeating this account is not additional evidence.
Source context — Vladonix and Endoluten combined-use report: Original post, not a commenter. Five each is cumulative so far, not a daily or per-use amount. Two products, unstated strength/frequency, no completed-course outcome. Joke reply excluded.
Source context — Ten-day Endoluten dream diary: One anonymous uncontrolled account; capsule strength, batch and other factors unverified. Proposed repeat schedule not a demonstrated cycle. Same person as follow-up ledger source.
Source context — Same diarist's later libido and dream recollections: Same reporter as diary, not independent confirmation. Recollection conflicts with early dream recall; exact recovery interval and later-comment dates not verified from relative timestamps.
Doses people talk about
| Capsule accounts | One diary used two oral capsules daily with a meal for ten days; a separate long-term user described one daily. Neither stated capsule strength. |
|---|---|
| Retail content | A reproduced label lists 10 mg peptide complex per capsule, with 1–2 capsules 1–2 times daily for a month. The 0.2 g total capsule weight is not peptide content; these are retail directions. |
| Stack total | The Vladonix–Endoluten author had taken about five capsules of each in total so far, not five of each daily or per administration. |
Notes
One diary: 2 oral capsules per day. The writer described 20 capsules over ten days, with a meal. Their capsule strength was not stated, so a milligram total cannot be verified from this account. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
One longer-term account: 1 capsule daily. Mikey described ongoing oral use instead of the short two-capsule course they referenced. Strength was unstated; this is an individual pattern, not an established maintenance dose. Mikey's capsule preference and ongoing use (Personal report · Accessed 2026-09-30)
10 mg is peptide-complex content per capsule. Qi's panel gives 20 mg per two capsules; total capsule weight is 0.2 g. Its one-month directions describe 1–2 capsules, 1–2 times daily with meals. These are retail directions, not an independently established effective dose. Qi Endoluten product panel and commercial description (Official context · Accessed 2026-09-30)
Five capsules each was a total taken so far. The Vladonix-Endoluten poster had taken about five of each when reporting deeper sleep. They did not describe five capsules of each per day or per administration. Vladonix and Endoluten combined-use report (Personal report · Accessed 2026-09-30)
Source context — Ten-day Endoluten dream diary: One anonymous uncontrolled account; capsule strength, batch and other factors unverified. Proposed repeat schedule not a demonstrated cycle. Same person as follow-up ledger source.
Source context — Mikey's capsule preference and ongoing use: Strength unstated. Prior four-month injections are not oral Endoluten history. Age-specific telomere percentages in #73 are slide-derived secondhand claims, not personal measurements or verified efficacy. Same mikey as comparison source.
Source context — Qi Endoluten product panel and commercial description: Commercial reproduced label, not regulator guidance or independent testing. official_context is the available label-context role, not endorsement of the vendor as an official health authority. Absorption/gene-expression/benefit and safety assurances not adopted; customer reviews were not visible in the opened body.
Source context — Vladonix and Endoluten combined-use report: Original post, not a commenter. Five each is cumulative so far, not a daily or per-use amount. Two products, unstated strength/frequency, no completed-course outcome. Joke reply excluded.
Half-life, onset & duration
| Felt onset | One diarist described relaxation on day one and dream recall after night one, without an elapsed-hour estimate. Another author's positive sleep/mood update came eight days into a course. |
|---|---|
| Felt duration | No dependable single-capsule window or return-to-baseline interval. The diarist later vaguely recalled the sexual effect lasting a couple of days. |
| Half-life | No dependable human estimate in these records. A mixture's clearance cannot be supplied by an unspecified peptide half-life or a course-long sleep report. |
Notes
Relaxation on day one; dream recall after night one. The diarist took it around 11 a.m. and later described feeling relaxed and sleepy. No elapsed time was given. Calm and lower sexual arousal appeared in the day-five update. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
Another course had positive updates after eight days. Alin began on May 5 and reported sleep and mood changes on May 13. That dates the report; it does not tell us the first effective dose or a predictable onset. Alin Samson's oral Endoluten course updates (Personal report · Accessed 2026-09-30)
A single-capsule effect window is unknown. Course-long observations cannot tell us whether a capsule feels noticeable for hours or days. No dependable duration or time to return to baseline emerges from these accounts. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
The sexual effect was later remembered as brief. The same diarist recalled it lasting probably a couple of days, while saying they did not really remember. This is uncertain retrospective recall, not a measured recovery interval. Same diarist's later libido and dream recollections (Personal report · Accessed 2026-09-30)
No dependable human estimate found. The available diaries describe experiences, not how quickly the capsule's components leave the body. Endoluten is a mixture, so an unspecified peptide's half-life cannot supply its clearance clock. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
Source context — Ten-day Endoluten dream diary: One anonymous uncontrolled account; capsule strength, batch and other factors unverified. Proposed repeat schedule not a demonstrated cycle. Same person as follow-up ledger source.
Source context — Alin Samson's oral Endoluten course updates: Anonymous unblinded account; no dose/strength given, expectations uncontrolled. Includes supplier endorsement, which is not reproduced. Mirror blog repeating this account is not additional evidence.
Source context — Same diarist's later libido and dream recollections: Same reporter as diary, not independent confirmation. Recollection conflicts with early dream recall; exact recovery interval and later-comment dates not verified from relative timestamps.
Cycles people discuss
| Separate course patterns | Ten-day and thirty-day courses appear in different accounts, alongside continuous use. Ten days every three months was proposed, not demonstrated as a repeat schedule. |
|---|
Notes
Ten-day and thirty-day courses both appear. The dream diary completed ten days. Alin described starting a thirty-day course and posted again near its end. These are separate accounts with different goals, not proof of an optimal course length. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30) · Alin Samson's oral Endoluten course updates (Personal report · Accessed 2026-09-30)
Quarterly repetition was proposed, not demonstrated. The diarist repeated a ten-days-every-three-months idea. Another user described continuous capsules. Neither establishes a safe break length, freedom from tolerance or a reason to keep using it indefinitely. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30) · Mikey's capsule preference and ongoing use (Personal report · Accessed 2026-09-30)
Source context — Ten-day Endoluten dream diary: One anonymous uncontrolled account; capsule strength, batch and other factors unverified. Proposed repeat schedule not a demonstrated cycle. Same person as follow-up ledger source.
Source context — Alin Samson's oral Endoluten course updates: Anonymous unblinded account; no dose/strength given, expectations uncontrolled. Includes supplier endorsement, which is not reproduced. Mirror blog repeating this account is not additional evidence.
Source context — Mikey's capsule preference and ongoing use: Strength unstated. Prior four-month injections are not oral Endoluten history. Age-specific telomere percentages in #73 are slide-derived secondhand claims, not personal measurements or verified efficacy. Same mikey as comparison source.
Stacks
| Vladonix and other bioregulators | A combined Vladonix–Endoluten account reports deeper sleep. Older discussion groups bioregulators by organ system, without establishing Endoluten's separate contribution or combination safety. |
|---|
Notes
Deeper sleep in a stack leaves attribution open. The Vladonix-Endoluten poster noticed deeper sleep early in combined use. Neither a daily dose nor a completed-course outcome was given, and Endoluten's separate contribution remains unknown. Vladonix and Endoluten combined-use report (Personal report · Accessed 2026-09-30)
Multi-bioregulator stacks: Often combined by organ system in protocols. [community]
Long-term safety and combinations remain uncertain. The original record flags animal-tissue composition, allergy or impurities, and poorly characterized long-term use. Multi-product reports do not establish which ingredient caused a change or whether combinations with medicines are safe.
Source context — Vladonix and Endoluten combined-use report: Original post, not a commenter. Five each is cumulative so far, not a daily or per-use amount. Two products, unstated strength/frequency, no completed-course outcome. Joke reply excluded.
Watch for
| Sleepiness and sexual changes | Calm came with marked reduced arousal by day five in one diary. Opposite libido accounts do not establish why different people responded differently. |
|---|---|
| Composition and label cautions | Animal-tissue composition, allergy/impurities and long-term use remain uncertain. The reproduced label lists pregnancy, nursing and ingredient intolerance as cautions; carriers include lactose. |
Notes
Calm can come with an unwanted sexual change. The dream diarist's reduced arousal was marked by day five. Their later follow-up says it was not after the first capsule. Sleepiness and changes in sexual interest are relevant even if someone also feels calmer. Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30) · Same diarist's later libido and dream recollections (Personal report · Accessed 2026-09-30)
Libido accounts point in opposite directions. Alin reported increased sexual interest and morning erections; the dream diarist reported reduced arousal. Different people and unverified products cannot establish why their experiences differed. Alin Samson's oral Endoluten course updates (Personal report · Accessed 2026-09-30) · Ten-day Endoluten dream diary (Personal report · Accessed 2026-09-30)
Long-term safety and combinations remain uncertain. The original record flags animal-tissue composition, allergy or impurities, and poorly characterized long-term use. Multi-product reports do not establish which ingredient caused a change or whether combinations with medicines are safe.
Pregnancy and nursing are label cautions. Qi lists pregnancy, lactation and intolerance to ingredients as contraindications; carriers include lactose. A capsule's convenience does not establish suitability. Qi Endoluten product panel and commercial description (Official context · Accessed 2026-09-30)
Source context — Ten-day Endoluten dream diary: One anonymous uncontrolled account; capsule strength, batch and other factors unverified. Proposed repeat schedule not a demonstrated cycle. Same person as follow-up ledger source.
Source context — Same diarist's later libido and dream recollections: Same reporter as diary, not independent confirmation. Recollection conflicts with early dream recall; exact recovery interval and later-comment dates not verified from relative timestamps.
Source context — Alin Samson's oral Endoluten course updates: Anonymous unblinded account; no dose/strength given, expectations uncontrolled. Includes supplier endorsement, which is not reproduced. Mirror blog repeating this account is not additional evidence.
Source context — Qi Endoluten product panel and commercial description: Commercial reproduced label, not regulator guidance or independent testing. official_context is the available label-context role, not endorsement of the vendor as an official health authority. Absorption/gene-expression/benefit and safety assurances not adopted; customer reviews were not visible in the opened body.
Full notes
Endoluten is an oral animal-pineal peptide complex discussed for sleep, calm and longevity. Reports include better sleep and reduced mental chatter, but also reduced sexual arousal and no lucid-dream benefit. These experiences do not establish longer life or reliable hormone changes.
What Endoluten actually is
- A-8 is a tissue-derived mixture. The retail identity is a peptide complex from young-animal pineal tissue. Bioregulator is the term used for the idea of supporting the organ the extract came from; the name itself does not establish that effect. Official context
- Capsules and Epithalon are different products. Forums often call Endoluten oral Epithalon. That shorthand blurs an extract and a synthetic peptide. Capsule counts cannot be converted into an equivalent injection amount, and results from one form cannot simply be assigned to the other. Community LongeCity
What people hope to notice
- Better sleep and a calmer mood. Alin Samson's oral-course updates describe improved sleep, less anxiety and mild euphoria. A separate Vladonix-Endoluten account describes deeper sleep, but both products were used together. Personal report Personal report
- Dream recall is different from lucid dreaming. Remembering a dream does not mean recognizing that you are dreaming while it happens. The ten-day diarist recalled dreams early on but did not achieve the lucid dreams they wanted. Personal report
- Skin and longevity claims need a different standard. A longer-term user linked skin improvement to restarting capsules while acknowledging other anti-aging interventions. A visible skin change does not establish slower aging, repaired hormones or increased lifespan. Personal report Community
Doses people discuss
- One diary: 2 oral capsules per day. The writer described 20 capsules over ten days, with a meal. Their capsule strength was not stated, so a milligram total cannot be verified from this account. Personal report
- One longer-term account: 1 capsule daily. Mikey described ongoing oral use instead of the short two-capsule course they referenced. Strength was unstated; this is an individual pattern, not an established maintenance dose. Personal report
- Five capsules each was a total taken so far. The Vladonix-Endoluten poster had taken about five of each when reporting deeper sleep. They did not describe five capsules of each per day or per administration. Personal report
Half-life
- No dependable human estimate found. The available diaries describe experiences, not how quickly the capsule's components leave the body. Endoluten is a mixture, so an unspecified peptide's half-life cannot supply its clearance clock. Community Personal report
When people first notice something
- Relaxation on day one; dream recall after night one. The diarist took it around 11 a.m. and later described feeling relaxed and sleepy. No elapsed time was given. Calm and lower sexual arousal appeared in the day-five update. Personal report
- Another course had positive updates after eight days. Alin began on May 5 and reported sleep and mood changes on May 13. That dates the report; it does not tell us the first effective dose or a predictable onset. Personal report
How long changes last
- A single-capsule effect window is unknown. Course-long observations cannot tell us whether a capsule feels noticeable for hours or days. No dependable duration or time to return to baseline emerges from these accounts. Personal report Community
- The sexual effect was later remembered as brief. The same diarist recalled it lasting probably a couple of days, while saying they did not really remember. This is uncertain retrospective recall, not a measured recovery interval. Personal report
Courses and breaks
- Ten-day and thirty-day courses both appear. The dream diary completed ten days. Alin described starting a thirty-day course and posted again near its end. These are separate accounts with different goals, not proof of an optimal course length. Personal report Personal report
- Quarterly repetition was proposed, not demonstrated. The diarist repeated a ten-days-every-three-months idea. Another user described continuous capsules. Neither establishes a safe break length, freedom from tolerance or a reason to keep using it indefinitely. Personal report Personal report
Good to know
- Calm can come with an unwanted sexual change. The dream diarist's reduced arousal was marked by day five. Their later follow-up says it was not after the first capsule. Sleepiness and changes in sexual interest are relevant even if someone also feels calmer. Personal report Personal report
- Long-term safety and combinations remain uncertain. The original record flags animal-tissue composition, allergy or impurities, and poorly characterized long-term use. Multi-product reports do not establish which ingredient caused a change or whether combinations with medicines are safe. Community
- Pregnancy and nursing are label cautions. Qi lists pregnancy, lactation and intolerance to ingredients as contraindications; carriers include lactose. A capsule's convenience does not establish suitability. Official context
- Severe symptoms need medical attention. The preserved cautions include severe allergy, chest pain, new neurological symptoms and uncontrolled blood pressure or blood sugar. A forum's reassuring anecdote cannot explain those symptoms away. Community
Retail strength and course context
- 10 mg is peptide-complex content per capsule. Qi's panel gives 20 mg per two capsules; total capsule weight is 0.2 g. Its one-month directions describe 1–2 capsules, 1–2 times daily with meals. These are retail directions, not an independently established effective dose. Official context
- Seasonal courses come from retail culture. The original record preserves 10–30-day courses and repetition two or three times yearly as vendor literature. Those numbers do not establish lasting benefit or a universal community calendar. Community
From community experience
- Libido accounts point in opposite directions. Alin reported increased sexual interest and morning erections; the dream diarist reported reduced arousal. Different people and unverified products cannot establish why their experiences differed. Personal report Personal report
- Dream benefits were inconsistent even in one account. The diarist's early updates mention improved recall; a later recollection says there were no dreams, lucid or otherwise. The disagreement belongs within that person's story, rather than becoming two separate users or a reliable dream effect. Personal report Personal report
- Capsule preference does not prove superiority. Mikey could not distinguish several pineal products and preferred oral use because injections stung. Mike888 instead preferred Epithalon while still describing some Endoluten benefit. Neither comparison establishes equivalent exposure or better effectiveness. LongeCity
- Deeper sleep in a stack leaves attribution open. The Vladonix-Endoluten poster noticed deeper sleep early in combined use. Neither a daily dose nor a completed-course outcome was given, and Endoluten's separate contribution remains unknown. Personal report